Science
fromBusiness Matters
1 month agoUK to fast-track next-gen RNA therapies with 30m Darlington biofoundry
UK to build a £29.6m RNA biofoundry in Darlington to produce clinical‑grade RNA at scale and accelerate translation of RNA therapies to NHS patients.